Clinical trials in India: Balancing economic opportunity with the public health context

National Medical Journal of India

Volumn 19, Issue 2, 2006, Pages 57-59

  Dandona, Lalit ^a  

^a ADMINISTRATIVE STAFF COLLEGE OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; VACCINE;

CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC EVALUATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; INDIA; INVESTMENT; MEDICAL INSTRUMENTATION; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REGISTER; UNSPECIFIED SIDE EFFECT;

CLINICAL TRIALS; COOPERATIVE BEHAVIOR; DRUG APPROVAL; DRUG EVALUATION; DRUG INDUSTRY; HUMANS; INDIA; PUBLIC HEALTH; REGISTRIES; RESEARCH SUPPORT;

EID: 33646840120     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Nundy S, Gulhati CM. A new colonialism? Conducting clinical trials in India. N Engl J Med 2005;352:1633-6.
2. Bhatt A. 2005 for clinical trials: Milestone or speed breaker? Pharmabiz.com 14 July 2005. http://www.pharmabiz.com/article/ detnews.asp?articleid=28685§ionid=50
3. Gupta SK. India's emergence as a hub for clinical research. The Pharma Review December 2005. http://www.kppub.com/articles/ indian-pharmaceutical-industry-003/ indias-emergence-as-a-hub-for-clinical-research.html
4. Kahn J. A nation of guinea pigs. Wired Mag March 2006. http://www.wired.com/wired/archive/14.03/indiadrug.html
5. Ministry of Health and Family Welfare, Government of India. National health policy 2002. http://mohfw.nic.in/np2002.htm (accessed 13 March 2006)
6. Misra R, Chatterjee R, Rao S. India health report. New Delhi:Oxford University Press; 2003.
7. Dandona L, Tandon N, Sahni P. Academic medicine and health improvements in India. Natl Med J India 2005;18:53-8.
8. Dandona L, Sivan YS, Jyothi MN, Bhasker VSU, Dandona R. The lack of public health research output from India. BMC Public Health 2004;4:55. http://www.biomedcentral.com/1471-2458/4/55/
9. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al; International Committee of Medical Journal Editors. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Lancet 2004;364:911-12.
10. Topol EJ. Failing the public health - rofecoxib, Merck, and the FDA. N Engl J Med 2004;351:1707-9.
11. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. BMJ 2005;330:396.
12. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 2005;353:2779-87.
13. Haug C, Gøtzsche PC, Schroeder TV. Registries and registration of clinical trials. N Engl J Med 2005;353:2811-12.
14. Bhatt A, Sewlikar S. Registering clinical trials in India. Natl Med J India 2006;19:1-3.
15. Krishnakumar R. Ethics on trial. Frontline, 4-17 August 2001. http://www.frontlineonnet.com/fl1816/18161230.htm
16. Fleck F. Clinical trials without ethical review under the spotlight. Bull World Health Organ 2004;82:314.
17. Central Drugs Control Administration of India. http://cdsco.nic.in/html/ central.htm (accessed 13 March 2006)
18. Reddy KS. Establishing schools of public health in India. In: Matlin S (ed). Global Forum update on research for health. Volume 2. Poverty, equity and health research. Geneva:Global Forum for Health Research; 2005:149-53.
19. Freidman TL. The world is flat: A brief history of the twenty-first century. New York:Farrar, Straus and Giroux; 2005.
20. Zakaria F. The earth's learning curve. Newsweek issues 2006: The knowledge revolution. http://www.msnbc.msn.com/id/10206249/site/newsweek/ (accessed 13 March 2006).